News releases Year None20242023202220212019 Dec 19, 2024 Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201 PDF Version Nov 20, 2024 Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data PDF Version Nov 12, 2024 Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024 PDF Version Nov 11, 2024 Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201 PDF Version Aug 29, 2024 Pyxis Oncology to Participate in Two Upcoming Investor Conferences PDF Version Aug 14, 2024 Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 PDF Version Jul 29, 2024 Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference PDF Version Jun 28, 2024 Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version Jun 10, 2024 Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger PDF Version May 30, 2024 Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference PDF Version Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 19
Year None20242023202220212019 Dec 19, 2024 Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201 PDF Version Nov 20, 2024 Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data PDF Version Nov 12, 2024 Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024 PDF Version Nov 11, 2024 Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201 PDF Version Aug 29, 2024 Pyxis Oncology to Participate in Two Upcoming Investor Conferences PDF Version Aug 14, 2024 Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 PDF Version Jul 29, 2024 Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference PDF Version Jun 28, 2024 Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version Jun 10, 2024 Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger PDF Version May 30, 2024 Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference PDF Version Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 19
